Table 4 Clinical characteristics of RA patients with pathology-proved ANCA-associated glomerulonephritis and primary glomerulonephritis
From: Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
ANCA-associated glomerulonephritis (n = 9) | Primary glomerulonephritis (n = 23)a | P | |
|---|---|---|---|
Age (ys) | 49 ± 21 | 51 ± 11 | .75 |
Female | 7 (77.8%) | 18 (78.3%) | 1.00 |
Duration of rheumatoid arthritis (ys) | 5 (4–20) | 9(1–14) | .49 |
Hemoglobin (g/L) | 97 ± 19 | 120 ± 21 | .009 |
ESR (mm/h) | 66 ± 42 | 71 ± 31 | .70 |
eGFR [ml.min−1.(1.73 m2)−1] | 24.4 ± 15.1 | 84.8 ± 21.2 | <.001 |
Serum albumin (g/L) | 35 ± 7 | 27 ± 9 | .018 |
24-h urine protein (g) | 1.73 (0.37,4.47) | 4.20 (2.31,9.07) | .07 |
Hematuria | 9 (100.0%) | 19 (82.6%) | .30 |
Treated with immunosuppressants | 5 (55.6%) | 12 (52.2%) | 1.00 |